Company Active LTD

Company profile

Naitive Technologies Limited

Naitive Technologies Limited is a UK company with status active founded in 2018 based in East of England.

CRN
11145951
Founded
2018
Age
8

Overview

Legal name
NAITIVE TECHNOLOGIES LIMITED
Region
East of England
Registered address
C/O MISHCON DE REYA
FOUR STATION SQUARE
CAMBRIDGE
ENGLAND
CB1 2GE
Insolvency history
No

Latest accounts

Financial period: 1 Feb 2024 to 31 Jan 2025

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
22

Company events

Reference milestones and recent Companies House filing stream events.

9 events
31 Oct
2027

Accounts due

Accounts Due

Next accounts due date

27 Apr
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

13 Apr
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

25 Mar
2026

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzUxMjMzMzU0N2FkaXF6a2N4

Published 25 Mar 2026 14:45

31 Jan
2026

Accounts filed

Accounts

Last accounts made up date

17 Nov
2024

Resolution

Resolution

RESOLUTIONS | Transaction WURGQlIxRERhZGlxemtjeA | Paper/PDF filed

Published 19 Nov 2024 11:26

17 Nov
2024

Resolution

Resolution

RESOLUTIONS | Transaction WURGQlIyRzNhZGlxemtjeA | Paper/PDF filed

Published 19 Nov 2024 10:25

25 Sep
2024

Capital Allotment Shares

Capital

SH01 | Transaction MzQzNzIwMzE0NmFkaXF6a2N4

Published 25 Sep 2024 01:23

11 Jan
2018

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2022
Funded years
2022, 2023, 2024
Age at first award
4 years

Projects

2024 Collaborative R&D Lead participant

Extending Machine Learning Driven Diagnosis of Low Bone Density from X-Rays

1 May 2024 to 30 Apr 2025

Awarded
£334,365
Total cost £477,664

1 in 3 women and 1 in 5 men over 50 will experience an osteoporotic fracture in their lifetime. Every year in the UK, over 500,000 people receive hospital treatment for fragility fractures because of osteoporosis, costing the NHS over £4.7bn. The cost extends well beyond immediate medical care. After a hip fracture, 40% of patients cannot walk independent...

2023 Collaborative R&D Lead participant

Clinical Validation of OsteoSight - AI technology for incidental detection of osteoporosis

1 Nov 2023 to 31 Jul 2025

Awarded
£370,695
Total cost £529,564

Every year in the UK, over 500,000 people receive hospital treatment for fragility fractures as a result of osteoporosis, costing the NHS over £4bn. The cost extends well beyond immediate medical care. After a hip fracture, 40% of patients cannot walk independently and 10--20% need permanent residential care. If diagnosed early, osteoporosis can be effect...

2022 Collaborative R&D Lead participant

Machine Learning Driven Diagnosis of Low Bone Density on Plain-Film X-Rays

1 Nov 2022 to 31 Oct 2023

Awarded
£347,825
Total cost £496,893

Osteoporosis is characterised by a degradation of the bone mass and an alteration of the bone microarchitecture. It is estimated that more than 200M people are suffering from osteoporosis worldwide and this number is expected to increase steadily due to changing demographics. If untreated, osteoporosis can lead to fractures which are not only disabling fo...

Product types

Collaborative R&D